Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.


Strengths

● The group's high margin levels account for strong profits.

● Its low valuation, with P/E ratio at 9.96 and 10.9 for the ongoing fiscal year and 2027 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The stock, which is currently worth 2026 to 0.63 times its sales, is clearly overvalued in comparison with peers.

● The company's share price in relation to its net book value makes it look relatively cheap.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● This company will be of major interest to investors in search of a high dividend stock.

● Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● Over the past four months, analysts' average price target has been revised upwards significantly.

● The group usually releases upbeat results with huge surprise rates.


Weaknesses

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.